Search Results

Emerging Treatments in Cystic Fibrosis

Authors: Jones, Andrew M.; Helm, Jennifer M.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1903-1910(8)

Publisher: Adis International

Targeting drugs to the airways: the role of spacer devices

Authors: Lavorini, Federico; Fontana, Giovanni A

Source: Expert Opinion on Drug Delivery, Volume 6, Number 1, January 2009 , pp. 91-102(12)

Publisher: Informa Healthcare

Efficacy and Safety of Indacaterol, a New 24-hour β 2-Agonist, in Patients with Asthma: A Dose-Ranging Study

Authors: Kanniess, Frank; Boulet, Louis-Philippe; Pierzchala, Wladyslaw; Cameron, Ray; Owen, Roger; Higgins, Mark

Source: Journal of Asthma, Volume 45, Number 10, December 2008 , pp. 887-892(6)

Publisher: Informa Healthcare

Prospective, Randomized Cross-Over Trial to Assess the Ability of a Dry-Powder Inhaler to Reverse the Local Side Effects of Pressurized Metered-Dose Inhalers

Authors: Bhalla, R. K.; Watson, G.; Taylor, W.; Jones, A. S.; Roland, N. J.

Source: Journal of Asthma, Volume 45, Number 9, November 2008 , pp. 814-819(6)

Publisher: Informa Healthcare

Budesonide/formoterol in the treatment of asthma

Authors: Lee, Christina; Corren, Jonathan

Source: Expert Review of Respiratory Medicine, Volume 2, Number 5, October 2008 , pp. 551-564(14)

Publisher: Expert Reviews

The Spray Drying of Unfractionated Heparin: Optimization of the Operating Parameters

Authors: Shur, Jagdeep; Nevell, Thomas; Shute, Janis; Smith, James

Source: Drug Development and Industrial Pharmacy, Volume 34, Number 6, June 2008 , pp. 559-568(10)

Publisher: Informa Healthcare

For an acute exacerbation of chronic obstructive pulmonary disease, formoterol can be delivered effectively via a dry-powder inhaler

Source: Inpharma, Volume 1, Number 1639, 2008-05-24 , pp. 21-21(1)

Publisher: Adis International

Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study

Authors: LaForce, C.; Alexander, M.; Deckelmann, R.; Fabbri, L. M.; Aisanov, Z.; Cameron, R.; Owen, R.; Higgins, M.

Source: Allergy, Volume 63, Number 1, January 2008 , pp. 103-111(9)

Publisher: Blackwell Publishing

Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease

Author: Prenner, Bruce M

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 17, December 2007 , pp. 3069-3084(16)

Publisher: Informa Healthcare

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma

Authors: Morice, A. H.; Peterson, S.; Beckman, O.; Osmanliev, D.

Source: International Journal of Clinical Practice, Volume 61, Number 11, November 2007 , pp. 1874-1883(10)

Publisher: Blackwell Publishing

Inhalation devices for long-acting β₂-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

Authors: Molimard, Mathieu; Till, Denise; Stenglein, Stephan; Singh, Dilraj; Krummen, Markus

Source: Current Medical Research and Opinion, Volume 23, Number 10, October 2007 , pp. 2405-2413(9)

Publisher: Informa Healthcare

Mometasone furoate dry-powder inhaler for the control of persistent asthma

Author: D'Urzo, Anthony

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 16, November 2007 , pp. 2871-2884(14)

Publisher: Informa Healthcare

Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis

Authors: Rachelefsky, Gary S.; Liao, Yuning; Faruqi, Rab

Source: Annals of Allergy, Asthma and Immunology, Volume 98, Number 3, March 2007 , pp. 225-238(14)

Publisher: American College of Allergy, Asthma, & Immunology

Combination Therapy for Asthma: Perspectives of the Patient, Provider, and Payer

Authors: Farber, Harold J.; Glauber, James

Source: Disease Management & Health Outcomes, Volume 14, Number 6, 2006 , pp. 353-368(16)

Publisher: Adis International

Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism

Authors: Lavorini, Federico; Geri, Pietro; Mariani, Laura; Marmai, Cecilia; Maluccio, Nazzarena Maria; Pistolesi, Massimo; Fontana, Giovanni A.

Source: British Journal of Clinical Pharmacology, Volume 62, Number 4, October 2006 , pp. 403-411(9)

Publisher: Blackwell Publishing

Performance of Turbuhaler® in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma: Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose Variability

Authors: Selroos, Olof; Borgström, Lars; Ingelf, Jarl

Source: Treatments in Respiratory Medicine, Volume 5, Number 5, 2006 , pp. 305-315(11)

Publisher: Adis International

Additive benefits of tiotropium in COPD patients treated with long-acting β₂ agonists and corticosteroids

Authors: PERNG, Diahn-Warng; WU, Cheng-Che; SU, Kang-Cheng; LEE, Yu-Chin; PERNG, Reury-Perng; TAO, Chi-Wei

Source: Respirology, Volume 11, Number 5, September 2006 , pp. 598-602(5)

Publisher: Blackwell Publishing

Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease

Authors: Centanni, Stefano; Di Marco, Fabiano

Source: Expert Opinion on Pharmacotherapy, Volume 6, Number 14, 1 November 2005 , pp. 2525-2534(10)

Publisher: Informa Healthcare

Liquid-Spray or Dry-Powder Systems for Inhaled Delivery of Peptide and Proteins?

Authors: Garcia-Contreras Lucila; Smyth Hugh D.C.

Source: American Journal of Drug Delivery, Volume 3, Number 1, 2005 , pp. 29-45(17)

Publisher: Adis International

Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction

Authors: Lavorini, Federico; Geri, Pietro; Luperini, Martina; Maluccio, Nazzarena M.; Mariani, Laura; Marmai, Cecilia; Pistolesi, Massimo; Fontana, Giovanni A.

Source: British Journal of Clinical Pharmacology, Volume 58, Number 5, November 2004 , pp. 512-520(9)

Publisher: Blackwell Publishing